The present invention relates to aryloxyethylamine compounds of the formula Iand the physiologically tolerated acid addition salts thereof. The variables have the meanings given in the claims and the description. The invention also relates to the use of a compound of the formula I or a phaceutically acceptable salt thereof for preparing a pharmaceutical composition for the treatment of a medical disorder susceptible to treatment with a dopamine D3 receptor ligand.本發明係關於式I之芳氧基乙胺化合物及其生理學上可耐受之酸加成鹽。變數具有在申請專利範圍及說明書中給出之含義。本發明亦係關於式I化合物或其醫藥學上可接受之鹽於製備供治療可感受多巴胺D3受體配位體治療法之醫學病症之醫藥組合物上的用途。
